Cancervax Corp.

Appointments And Advancements.
BIOWORLD Today; 11/4/2009; 1189 words; ...appointed John North to its board. BioWisdom Ltd., of Cambridge, Mass., appointed Julie Barnes to its board. CancerVax Corp., of Carlsbad, Calif., appointed Martin Mattingly executive vice president. Dharmacon Inc., of Lafayette...

Other News To Note.
BIOWORLD Today; 11/4/2009; 2862 words; ...95.7 percent of all of them. o CancerVax Corp., of Carlsbad, Calif., presented...terms were not disclosed. o Chiron Corp., of Emeryville, Calif., granted...terms were not disclosed. o Elan Corp. plc, of Dublin, Ireland, said...

CancerVax Resuming Phase III Trials Of Canvaxin In Melanoma.
BIOWORLD Today; 11/4/2009; 1274 words; Staff Writer CancerVax Corp. is springing back into action as...practice or safety concerns. According to CancerVax, its submission of supplementary information...developed to be given to all patients," CancerVax President and CEO David Hale told BioWorld...

CancerVax Gains $41M In Series C Round For Phase III Candidate.
BIOWORLD Today; 11/4/2009; 1100 words; Staff Writer CancerVax Corp. secured $41 million in a Series...at least a year, said Julie Ames, CancerVax's director of corporate communications...following the investment. Privately held CancerVax, whose officials declined to comment...

Ambrx Licenses HGH Program To Merck Serono.
BIOWORLD Today; 11/3/2009; 1135 words; ...ARX201, he said. Ambrx's ex-CEO Martin Mattingly also had ties to Merck Serono through a previous position at CancerVax Corp., which was a Serono partner. Beyond its HGH program, Ambrx has applied its ReCODE pegylation technology to interferon...